David Goeddel V Net Worth & Insider Trades
David Goeddel V - Director, Ngm Biopharmaceuticals Inc
What is David Goeddel V's Net Worth?
The current estimated net worth of Ngm Biopharmaceuticals Inc's Director, David Goeddel V, is estimated to be about $600.03M . David Goeddel V owns about 1,027,231 units of Ngm Biopharmaceuticals Inc common stock. In the last 4 years at Ngm Biopharmaceuticals Inc, David Goeddel V has sold an estimated value of $0 worth.
What is David Goeddel V's Past Insider Trading?
David Goeddel V's largest purchase order was 15,158,134 units , worth over $30M on April 10, 2019. In total, David Goeddel V has made about 67 transactions over 4 years of their time at Ngm Biopharmaceuticals Inc. David Goeddel V usually trades in May, with the busiest year in 2019. The most recent transaction was a purchase order of 184,272 units , worth over $921.11K on February 1, 2023.
DAVID GOEDDEL V
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was David Goeddel V's Salary in 2020?
As Director of Ngm Biopharmaceuticals Inc, David Goeddel V has a total base salary of $525,000 . David Goeddel V received compensation valued at about $4,559,630 in 2020 after becoming Director. The vast majority of their compensation came in the form of a bonus of $200,000 , option awards of $3,833,880 , and other compensation of $750 .
What is David Goeddel V's' Mailing Address?
- Mailing address is C/o Column Group Lp 1700 Owens Street, Suite 500 San Francisco CA 94158 CA
Ngm Biopharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| David J. Woodhouse, Ph.D. | 2020 | $525,000 | $200,000 | $3,833,880 | $750 | $4,559,630 |
| David J. Woodhouse, Ph.D. | 2019 | $490,000 | $125,000 | $1,476,400 | $750 | $2,092,150 |
| Siobhan Nolan Mangini | 2020 | $199,695 | $155,000 | $3,458,520 | $750 | $3,813,965 |
| Jin-Long Chen, Ph.D. | 2020 | $515,000 | $175,000 | $1,677,323 | $750 | $2,368,073 |
| Jin-Long Chen, Ph.D. | 2019 | $500,000 | $125,000 | $1,291,850 | $750 | $1,917,600 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1426332/000162828021007942/ngmbiopharmaceuticalsinc-d.htm
What are Ngm Biopharmaceuticals Inc's Past Insider Trades?
Ngm Biopharmaceuticals Inc's most recent insider trade came on February 1, 2023 by Group Column, Column Group GP Lp, Column Group Iii Lp, Column Group Iiia Lp, Column Group Iv Lp, Column Group Iva Lp, Column Group Iv GP Lp, Tcg Iv GP Llc, Column Group Opportunity Iii Lp and Column Group Opportunity Iii GP Lp who bought 184,272 units worth $921.11K . In the last 4 years, insiders at Ngm Biopharmaceuticals Inc have sold an estimated value of $12.8M and bought an estimated value of $365.51M worth of shares. Insider trading is most common in May, with the busiest year in 2019. The most active traders at the company are Group Column, Director, David Goeddel V, Director, and Peter Svennilson .
NGM BIOPHARMACEUTICALS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||